In 2003, the first human genome was sequenced through the collaborative effort of 20 research centers. It cost nearly $3 billion.
Almost 12 years later, the cost of sequencing has come down faster than Moore’s law. We can now sequence an entire genome for $2,000 to $3,ooo in a fraction of the time it took to sequence that first human genome.
In the first part of our conversation on genomics, we examine the ways in which genetic data is used to personalize medicine, and take a look at what’s being done in the clinical setting. Specifically, we’ll address how this technology has changed what we know about cancer and discuss some of the limitations of what we can accomplish through genome analysis.
- Jean Claude Zenklusen: Director of The Cancer Genome Atlas Project
- Chris Corless: Medical director at the Cancer Pathology Share Resource at Oregon Health & Science University
In the next part of our conversation, we’ll look into some of the legal and ethical concerns surrounding genetic research.